$NVAX The Novavax vaccine candidate works in a similar way to the UQ version, in that both use a slightly different technique to generate a protein that looks like the protein on the surface of SARS-CoV-2, causing an immune response in humans Unfortunately, this principle is relatively fragile. Altered mutated surface protein variants of the selected target protein on the mutated virus are not recognized. I think Novavax has no future to become a vaccine candidate.